ValiRx - Article accepted for publication of VAL401
VAL Tue, 18 Dec 2018, 12:00pm GMT
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
ValiRx, the clinical stage biotechnology company, is pleased to announce the acceptance for publication of the first article containing results from the VAL401 clinical trial by the European Journal of Drug Metabolism and Pharmacokinetics.